openPR Logo
Press release

Elevated Down Syndrome Incidence And Maternal Age Is Fueling Growth In Non-Invasive Prenatal Testing Market: A Significant Driver Propelling The Non-invasive Prenatal Testing Market In 2025

06-11-2025 03:09 PM CET | Health & Medicine

Press release from: The Business Research Company

Non-invasive Prenatal Testing

Non-invasive Prenatal Testing

The Non-invasive Prenatal Testing Market Report by The Business Research Company delivers a detailed market assessment, covering size projections from 2025 to 2034. This report explores crucial market trends, major drivers and market segmentation by [key segment categories].

What Is the Non-invasive Prenatal Testing Market Size and Projected Growth Rate?
The non-invasive prenatal testing market has expanded rapidly in recent years. It will increase from $5.48 billion in 2024 to $6.28 billion in 2025 at a compound annual growth rate (CAGR) of 14.7%. This growth can be attributed to improved accuracy in testing, reduced risk for mothers, increased maternal age, growing awareness, and updated clinical guidelines.

The non-invasive prenatal testing market is expected to see rapid expansion, with the market projected to grow to $10.95 billion by 2029 at a CAGR of 14.9%. Growth drivers include broader test availability, maternal age-related concerns, telehealth growth, and better anomaly detection. Trends involve expansion of test panels, increased NIPT adoption, technological progress, and non-invasive fetal diagnosis innovations.

Purchase the full report for exclusive industry analysis:
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=2492

What Are the Major Segments in the Non-invasive Prenatal Testing Market?
The non-invasive prenatal testing market covered in this report is segmented -

1) By Type: Consumables, Instruments
2) By Application: Trisomy, Microdeletion, Genetics, Rh factor
3) By End User: Hospital, Diagnostic Labs

Subsegment:
1) By Consumables: Assay Kits, Reagents, Disposables
2) By Instruments: Next-Generation Sequencers (NGS), Polymerase Chain Reaction (PCR) Systems, Ultrasound Devices, Others (Microarrays And Mass Spectrometers)

Get your free sample here:
https://www.thebusinessresearchcompany.com/sample.aspx?id=2492&type=smp

What Are The Driving Non-invasive Prenatal Testing Market Evolution?
The high occurrence of Down syndrome, especially among older mothers, is a major driver of the non-invasive prenatal testing (NIPT) market. Down syndrome, caused by an extra chromosome 21, impacts cognitive and physical development. NIPT offers a safe, non-invasive method to detect the condition with over 99% accuracy and no risk of miscarriage. According to the CDC and National Down Syndrome Society, in the U.S., 1 in 700 babies is born with the condition, with 80% of these births occurring in older women, which supports the increasing demand for NIPT.

Which Firms Dominate The Non-invasive Prenatal Testing Market Segments?
Major companies operating in the non-invasive prenatal testing market include F. Hoffmann-La Roche AG, Illumina Inc., Laboratory Corporation of America Holdings, Natera Inc., PerkinElmer Inc., Quest Diagnostics Inc., Agilent Technologies Inc., BGI Diagnosis Co Ltd., Berry Genomics Co, LifeCodexx AG, Myriad Genetics Inc., NIPD Genetics Co Ltd., Sequenom Inc., Annoroad Gene Technology Co Ltd., Centogene AG, Counsyl Inc., EUROFINS Genoma Group, Eurofins Scientific SE, Next Biosciences, Premaitha Health Plc, Ariosa Diagnostics Inc., Beijing Genomics Institute, Yourgene Health PLC, GE Healthcare Technologies Inc., Koninklijke Philips NV, Thermo Fisher Scientific Inc., Pacific Biosciences of California Inc., QIAGEN NV, MedGenome Labs Ltd., Progenity Inc.

What Trends Are Driving Growth in The Non-invasive Prenatal Testing Market?
The implementation of next-generation sequencing has significantly increased the speed, efficiency, and scalability of DNA sequencing, making it possible to analyze large volumes of genetic material simultaneously. This technology has been adopted by major companies such as Illumina, Eurofins, Natera, Roche, and Annoroad, particularly for non-invasive prenatal testing. Notably, the CFDA approved Annoroad's NextSeq 550AR sequencing system for medical use.

Get the full report for exclusive industry analysis:
https://www.thebusinessresearchcompany.com/report/non-invasive-prenatal-testing-global-market-report

Which Is The Largest Region In The Non-invasive Prenatal Testing Market?
North America was the largest region in the non-invasive prenatal testing market in 2023. Western Europe was the second largest region in the non-invasive prenatal testing market. The regions covered in the non-invasive prenatal testing market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa

Frequently Asked Questions:
1. What Is the Market Size and Growth Rate of the Non-invasive Prenatal Testing Market?
2. What is the CAGR expected in the Non-invasive Prenatal Testing Market?
3. What Are the Key Innovations Transforming the Non-invasive Prenatal Testing Industry?
4. Which Region Is Leading the Non-invasive Prenatal Testing Market?

Connect with us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company,
Twitter: https://twitter.com/tbrc_info,
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ.

Contact Us
Europe: +44 207 1930 708,
Asia: +91 88972 63534,
Americas: +1 315 623 0293 or
Email: mailto:info@tbrc.info

Learn More About The Business Research Company
With over 15,000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Our flagship product, the Global Market Model delivers comprehensive and updated forecasts to support informed decision-making.

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Elevated Down Syndrome Incidence And Maternal Age Is Fueling Growth In Non-Invasive Prenatal Testing Market: A Significant Driver Propelling The Non-invasive Prenatal Testing Market In 2025 here

News-ID: 4061971 • Views:

More Releases from The Business Research Company

Competitive Analysis: Leading Companies and New Entrants in the Wire Arc Additive Manufacturing Cell Market
Competitive Analysis: Leading Companies and New Entrants in the Wire Arc Additiv …
The wire arc additive manufacturing cell market is rapidly gaining traction as industries increasingly embrace advanced metal 3D printing technologies. With significant investments and technological breakthroughs, this sector is set to experience remarkable growth, transforming manufacturing processes across multiple fields. Let's explore the market's size, influential players, key trends, and segmentation to understand its future trajectory. Projected Expansion of the Wire Arc Additive Manufacturing Cell Market The wire arc additive manufacturing cell
Future Perspectives: Key Trends Shaping the Viscosupplementation Treatment for Arthritis Market Until 2029
Future Perspectives: Key Trends Shaping the Viscosupplementation Treatment for A …
The viscosupplementation treatment for arthritis market is on the verge of significant expansion, driven by advances in medical technology and a growing demand for effective arthritis therapies. With increasing awareness around early intervention and new treatment options, this sector is poised for rapid development over the coming years. Let's explore the market size, key players, emerging trends, and segment-wise forecasts that define this growing industry. Projected Market Growth and Size of
Segmentation, Major Trends, and Competitive Overview of the Viral Vector Development Service Market
Segmentation, Major Trends, and Competitive Overview of the Viral Vector Develop …
The viral vector development service market is set to experience substantial growth in the coming years, driven by technological progress and increasing demand from various sectors. As gene therapies and advanced treatments gain prominence, the need for efficient viral vector production and development is becoming more critical. Let's explore the market size projections, key players, emerging trends, and the segment structure shaping this industry's future. Projected Expansion and Market Size of
Competitive Landscape: Leading Companies and New Entrants in the Transient Elastography Market
Competitive Landscape: Leading Companies and New Entrants in the Transient Elast …
The transient elastography market is poised for substantial expansion as advancements in healthcare diagnostics continue to evolve. Increasing emphasis on non-invasive techniques and early disease detection is driving widespread adoption, setting the stage for strong market growth in the coming years. Let's explore the current market valuation, leading players, emerging innovations, and key segments shaping this industry. Projected Market Value and Growth of the Transient Elastography Market The transient elastography market is

All 5 Releases


More Releases for Prenatal

Non-Invasive Prenatal Testing (NIPT) Market Set to Transform Prenatal Care World …
Market Overview The global non-invasive prenatal testing NIPT market reached US$ 6.31 billion in 2023 and increased to US$ 7.35 billion in 2024. It is projected to reach US$ 22.41 billion by 2033, growing at a compound annual growth rate CAGR of 13.2% during the forecast period 2025-2033. The market is driven by the rising prevalence of chromosomal abnormalities, increasing maternal age, and growing demand for safe, non-invasive screening methods. NIPT
Unlocking the Future of Prenatal Care: Insights into the Australia Non-Invasive …
Australia's NIPT market is growing as more parents choose safe, early screening for chromosomal abnormalities. Driven by rising maternal age, advanced sequencing technology, and increasing awareness, NIPT offers high accuracy without invasive procedures. As labs expand test panels and policymakers consider broader reimbursement, NIPT is reshaping prenatal care, making comprehensive and reliable insights accessible to expecting families across Australia. The Australian non-invasive prenatal testing (NIPT) market is undergoing remarkable growth, transforming
Revolutionizing Prenatal Care: Insights into the Growing Non-Invasive Prenatal T …
Mordor Intelligence has published a new report on the Non-invasive Prenatal Testing Market, offering a comprehensive analysis of trends, growth drivers, and future projections. The global non-invasive prenatal testing (NIPT) market is projected to expand significantly, with expectations to grow from USD 3.90 billion in 2025 to USD 7.35 billion by 2030, reflecting a compound annual growth rate (CAGR) of 13.5%. This growth is primarily attributed to
Prenatal Diagnostics Market Companies Overview 2019 - 2027
Global Prenatal Diagnostics Market: Overview Prenatal diagnostics is a procedure for testing the fetus before birth to determine certain hereditary disorders such as Down's syndrome, genetic diseases, chromosome abnormalities, neural tube defects, and other conditions. In case of high risk related to the birth of a child, it can assist by conducting numerous procedures of genetic testing common testing, and screening. Report Overview @ https://www.transparencymarketresearch.com/prenatal-diagnostics-market.html The global prenatal diagnostics market is segmented on
Non-Invasive Prenatal Testing Market : Lucrative Opportunities
Non-Invasive Prenatal Testing Market: Introduction Transparency Market Research has published a new report titled 'Global Non-Invasive Prenatal Testing Market'. According to the report, the global non-invasive prenatal testing market was valued at approximately US$ 1.3 Bn in 2018. The global non-invasive prenatal testing market is expected to expand at a CAGR of 16.4% during the forecast period from 2019 to 2027. Overview Rise in prevalence of chronic conditions, such as cancer and diabetes,
Prenatal Vitamin Supplements Market: Rising Incidence of Prenatal Defects to Fue …
Global Prenatal Vitamin Supplements Market: Overview Prenatal vitamins are the mineral and vitamin supplements used by during their pregnancy for the healthy development of the fetus. Prenatal vitamins are also recommended by doctors before conception and post conception lactation period. These vitamins are like other common man multivitamins but with different concentration of vitamins and some special vitamins required during pregnancy. Most of these vitamins are prescribed as regulated by U.S.